Procter & Gamble Förvaltning
Förvaltning kriterier kontrolleras 4/4
Procter & Gamble VD är Shailesh Jejurikar, utsedd i Jan 2026, har en mandatperiod på mindre än ett år. totala årliga ersättningen är $ 9.59M, bestående av 12.1% lön 87.9% bonusar, inklusive företagsaktier och optioner. äger direkt 0.004% av företagets aktier, värda $ 12.81M. Den genomsnittliga mandatperioden för ledningsgruppen och styrelsen är 3.6 år respektive 4.7 år.
Viktig information
Shailesh Jejurikar
Verkställande direktör
US$9.6m
Total ersättning
| VD-lön i procent | 12.12% |
| Anställning som VD | less than a year |
| Ägande av VD | 0.004% |
| Ledningens genomsnittliga anställningstid | 3.6yrs |
| Styrelsens genomsnittliga mandatperiod | 4.7yrs |
Senaste uppdateringar av ledningen
Recent updates
Seeking Alpha • May 28
Procter & Gamble: Priced Like A Hyper Growth Tech Stock
Summary Procter & Gamble is reiterated a Sell due to overvaluation and a premature recovery thesis despite recent organic sales growth. Q3 showed encouraging 7% net sales growth and broad-based organic gains, but margins continued to contract and profitability remains under pressure. Procter & Gamble left full-year guidance unchanged, signaling tepid expectations for organic sales and core EPS growth, with management hinting at Middle East headwinds. Share buybacks fell sharply despite strong cash flow, suggesting management may see limited upside or overvaluation at current levels. Read the full article on Seeking Alpha
Uppdatering av berättelse • May 04
PG: Brand Partnerships And Product Pipeline Will Support Future Shareholder Returns
Analysts have trimmed their Procter & Gamble price target slightly to about $164.09, reflecting modestly lower assumptions for revenue and profit margins while applying a slightly higher future P/E outlook. What's in the News P&G maintained fiscal 2026 guidance, with all-in sales growth expected in a 1% to 5% range and diluted EPS growth targeted in a 1% to 6% range versus fiscal 2025 diluted EPS of US$6.51 (Corporate guidance).
Ny berättelse • Apr 24
Procter & Gamble (PG): The Beauty-Driven Beat and the Resilience of Staples
Procter & Gamble (PG) , the global vanguard of consumer staples, enters the afternoon of Friday, April 24, 2026 , as a beacon of stability following its Q3 Fiscal 2026 earnings report released this morning. The Cincinnati-based giant delivered a solid "beat-and-raise" performance, reporting Core EPS of $1.59 , surpassing the Wall Street consensus of $1.56.Uppdatering av berättelse • Apr 20
PG: Buybacks And Brand Partnerships Will Support Future Shareholder Returns
Analysts have slightly reduced their price target on Procter & Gamble to $164.18 from $166.95, reflecting modestly lower assumptions for revenue growth, profit margins, fair value, and future P/E multiples. What's in the News P&G revised its fiscal 2026 diluted EPS growth outlook to a range of 1% to 6%, from a prior range of 3% to 9%, citing higher non core restructuring charges, while keeping all in sales growth guidance at 1% to 5% versus the prior year (Corporate guidance).Uppdatering av berättelse • Apr 05
PG: Share Repurchases And Premium Portfolio Refresh Will Support Future Returns
Analysts have slightly reduced their average price target for Procter & Gamble to about $167 from $168, reflecting updated views on margins and forward P/E assumptions while keeping core growth expectations largely intact. What's in the News OLAY shared new skin aging research at the 2026 American Academy of Dermatology meeting, focusing on cell adhesion as a key factor in visible aging and applying these findings to peptide based products across the Regenerist line and the new Regenerist Treatments collection (Product announcement).Uppdatering av berättelse • Mar 22
PG: Product Refresh And Buybacks Will Support Future Earnings Resilience
Analysts kept their Procter & Gamble price target steady at $168. This reflects largely unchanged views on fair value, discount rate, revenue growth, profit margin, and future P/E assumptions.Uppdatering av berättelse • Mar 08
PG: Brand Refresh And Buybacks Will Support Stable Earnings Outlook
Analysts have maintained their Procter & Gamble price target at $168, reflecting unchanged assumptions around revenue growth, profit margins, and future P/E. This suggests that recent research has not materially shifted their valuation view.Uppdatering av berättelse • Feb 21
PG: Brand Activity And Buybacks Will Support Stable Margins And Outlook
Analysts have nudged their price target for Procter & Gamble higher to $168.00 from $167.45, reflecting updated assumptions for revenue growth, slightly higher profit margins and a marginally lower future P/E multiple. What's in the News Tide launched Tide evo, a 100% concentrated, waterless laundry tile with six cleaning layers and no plastic bottles, positioned to address demand for products that align with hygiene and sustainability preferences in the U.S. (Product related announcement) Head & Shoulders introduced BARE Itchy Scalp Relief Serum, aimed at providing clinically tested dandruff protection and itch relief between washes, with a nationwide U.S. launch planned for January 2026.Uppdatering av berättelse • Feb 07
PG: Premium Brand Extensions And Stable Margins Will Support A Balanced Outlook
Analysts have nudged their price target on Procter & Gamble slightly higher to US$167.45 from about US$165.32, reflecting updated assumptions for fair value, discount rate, revenue growth, profit margins and future P/E. What's in the News Old Spice launched the Spice Alchemist collection, a premium cologne-infused deodorant, body wash and body mist line positioned against high end fragrances.
Uppdatering av berättelse • Jan 25
Q2 2026 Update
Update narrative with most recent financial statements.Uppdatering av berättelse • Jan 23
PG: Share Repurchases And Margin Pressures Will Shape A Balanced Outlook
Analysts have trimmed their price target on Procter & Gamble to US$165 from US$168, citing updated views on revenue growth, profit margins, and the future P/E multiple. What's in the News P&G updated its fiscal 2026 guidance, keeping all in sales growth for the year in a range of 1% to 5% versus the prior year, while lowering the diluted EPS growth outlook to 1% to 6% from the previous 3% to 9% range, citing higher non core restructuring charges versus fiscal 2025 diluted EPS of US$6.51 (Corporate guidance).Uppdatering av berättelse • Jan 07
PG: Share Repurchase Will Support Future Upside With Stable Long Term Outlook
Narrative Update on Procter & Gamble The analyst price target for Procter & Gamble has shifted slightly, with updated assumptions around fair value at about $168.13, discount rate at 6.96%, revenue growth at roughly 3.12%, profit margin near 19.58%, and future P/E around 26.08x, as analysts fine tune their models on the company. What's in the News Pantene is partnering again with social media creator Alix Earle to promote the Abundant & Strong 3-Step System, including limited-edition Alix x Pantene Kits that bundle the three products with a free cosmetics bag and hairbrush for a limited time (product-related announcement).Uppdatering av berättelse • Dec 16
PG: Share Repurchase Will Support Future Upside Amid Stable Long Term Outlook
Analysts have nudged their price target for Procter & Gamble slightly lower to approximately $168.50 from about $169.05, reflecting modestly softer long term revenue growth expectations that are only partially offset by a marginally improved profit margin outlook and a slightly lower assumed future valuation multiple. What's in the News Pantene launched the Abundant & Strong Collection, a three step system clinically shown to reduce hair loss by up to 85% by targeting scalp oxidative stress with a Pro Vitamin Complex plus Niacinamide technology.Uppdatering av berättelse • Dec 02
PG: Share Repurchase And New Collections Will Drive Continued Momentum
Procter & Gamble's analyst price target remains unchanged at $169.05 as analysts maintain stable estimates based on consistent fair value metrics and minimal adjustments to key financial assumptions. What's in the News Pantene launches the Abundant & Strong Collection, a new three-step system designed to reduce hair loss by up to 85% and promote stronger, denser hair using antioxidant technology.Uppdatering av berättelse • Nov 18
PG: Share Buybacks And New Guidance Will Support Steady Uptrend
Analysts have maintained Procter & Gamble's price target at $169.05 per share. There have been only minor adjustments to underlying valuation factors, supporting a steady outlook for the company.Uppdatering av berättelse • Nov 03
PG: Share Buyback And Product Rollout Will Drive Long-Term Upside
Analysts have slightly raised their price target for Procter & Gamble to $169.05 from $168.64. They cite incremental improvements in revenue growth forecasts even as profit margin projections moderate.Uppdatering av berättelse • Oct 20
Rising Consumer Confidence And Product Investment Will Expand US Markets
Analysts have slightly lowered their price target for Procter & Gamble from $170.95 to $168.64 per share. They cite modest reductions in projected revenue growth, which are partially offset by improved profit margins and valuation multiples.Analysartikel • Aug 06
The Procter & Gamble Company (NYSE:PG) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?
NYSE:PG 1 Year Share Price vs Fair Value Explore Procter & Gamble's Fair Values from the Community and select yours The...Ny berättelse • Jul 21
Procter & Gamble: A Dividend Giant Facing Slowing Growth
United States: 48.21%1-Year Revenue Growth = 4.65%Analysartikel • Jun 27
The Procter & Gamble Company (NYSE:PG) Shares Could Be 21% Below Their Intrinsic Value Estimate
Key Insights The projected fair value for Procter & Gamble is US$200 based on 2 Stage Free Cash Flow to Equity Procter...Seeking Alpha • Apr 22
Procter & Gamble: Hold This Stodgy Stalwart
Summary Procter & Gamble is a global consumer product leader, with a strong market presence and consistent, albeit slow, growth in revenue and earnings. Despite being overvalued, PG's profitability remains robust, with reliable cash flow and a solid gross profit margin above industry medians. PG's valuation poses a risk, with a high PEG ratio indicating slow growth, yet it maintains a decent dividend yield and outpaces peers in performance. PG is a safe investment but lacks excitement; it's a hold due to its steady but lethargic growth and overvaluation concerns. Read the full article on Seeking AlphaAnalys av ersättningar till VD
| Datum | Total ersättning | Lön | Företagets resultat |
|---|---|---|---|
| Mar 31 2026 | n/a | n/a | US$16b |
| Dec 31 2025 | n/a | n/a | US$16b |
| Sep 30 2025 | n/a | n/a | US$16b |
| Jun 30 2025 | US$10m | US$1m | US$16b |
| Mar 31 2025 | n/a | n/a | US$15b |
| Dec 31 2024 | n/a | n/a | US$15b |
| Sep 30 2024 | n/a | n/a | US$14b |
| Jun 30 2024 | US$10m | US$1m | US$15b |
| Mar 31 2024 | n/a | n/a | US$15b |
| Dec 31 2023 | n/a | n/a | US$14b |
| Sep 30 2023 | n/a | n/a | US$15b |
| Jun 30 2023 | US$8m | US$1m | US$14b |
| Mar 31 2023 | n/a | n/a | US$14b |
| Dec 31 2022 | n/a | n/a | US$14b |
| Sep 30 2022 | n/a | n/a | US$14b |
| Jun 30 2022 | US$7m | US$953k | US$14b |
| Mar 31 2022 | n/a | n/a | US$14b |
| Dec 31 2021 | n/a | n/a | US$14b |
| Sep 30 2021 | n/a | n/a | US$14b |
| Jun 30 2021 | US$6m | US$798k | US$14b |
Ersättning vs marknad: Shailesh s total kompensation ($USD 9.59M ) är under genomsnittet för företag av liknande storlek på US marknaden ($USD 14.78M ).
Ersättning vs inkomst: Ersättningen från Shailesh har varit i linje med företagets resultat under det senaste året.
VD OCH KONCERNCHEF
Shailesh Jejurikar (57 yo)
less than a year
Anställning
US$9,591,687
Kompensation
Mr. Shailesh G. Jejurikar was Independent Director at Otis Worldwide Corporation (also known as Otis Elevator Company, Inc) since April 03, 2020 until September 9, 2025. He serves as CEO & President at The...
Ledningsgrupp
| Namn | Position | Anställning | Kompensation | Ägarskap |
|---|---|---|---|---|
| Executive Chairman | 4.8yrs | US$21.91m | 0.016% $ 55.4m | |
| CEO, President & Director | less than a year | US$9.59m | 0.0038% $ 12.8m | |
| Chief Financial Officer | 5.2yrs | US$8.52m | 0.0026% $ 8.8m | |
| Chief Executive Officer of Health Care | 8.3yrs | US$6.04m | 0.0033% $ 11.3m | |
| Chief Executive Officer of Fabric and Home Care and P&G Ventures | 1.3yrs | US$7.18m | 0.0022% $ 7.3m | |
| Senior VP & Chief Accounting Officer | 3.8yrs | inga uppgifter | 0.00018% $ 611.6k | |
| Chief Information Officer | 1.8yrs | inga uppgifter | inga uppgifter | |
| Senior Vice President of Investor Relations | no data | inga uppgifter | inga uppgifter | |
| Chief Legal Officer & Secretary | 4.3yrs | inga uppgifter | 0.0016% $ 5.4m | |
| Chief Communications Officer | 6.2yrs | inga uppgifter | inga uppgifter | |
| President of North America & Chief Sales Officer | no data | inga uppgifter | inga uppgifter | |
| Chief Human Resources Officer | 3.3yrs | US$7.48m | 0.00077% $ 2.6m |
3.6yrs
Genomsnittlig anställningstid
53.5yo
Genomsnittlig ålder
Erfaren ledning: PG s ledningsgrupp anses vara erfaren ( 3.6 års genomsnittlig anställningstid).
Styrelseledamöter
| Namn | Position | Anställning | Kompensation | Ägarskap |
|---|---|---|---|---|
| Executive Chairman | 4.8yrs | US$21.91m | 0.016% $ 55.4m | |
| CEO, President & Director | less than a year | US$9.59m | 0.0038% $ 12.8m | |
| Independent Director | 6.6yrs | US$370.00k | inga uppgifter | |
| Independent Director | 5.8yrs | US$340.00k | inga uppgifter | |
| Lead Independent Director | 8.2yrs | US$410.00k | 0.00054% $ 1.8m | |
| Independent Director | 3.6yrs | US$340.00k | inga uppgifter | |
| Independent Director | 3.1yrs | US$340.00k | inga uppgifter | |
| Independent Director | 2.6yrs | US$340.00k | inga uppgifter | |
| Independent Director | 5.3yrs | US$340.00k | inga uppgifter | |
| Independent Director | 8.9yrs | US$360.00k | inga uppgifter | |
| Independent Director | 4.6yrs | US$340.00k | inga uppgifter | |
| Independent Director | 3.1yrs | US$340.00k | inga uppgifter |
4.7yrs
Genomsnittlig anställningstid
60yo
Genomsnittlig ålder
Erfaren styrelse: PG s styrelse anses vara erfaren ( 4.7 års genomsnittlig mandatperiod).
Företagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/05/29 22:36 |
| Aktiekurs vid dagens slut | 2026/05/29 00:00 |
| Intäkter | 2026/03/31 |
| Årlig intjäning | 2025/06/30 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som användes för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och tutorials på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
The Procter & Gamble Company bevakas av 43 analytiker. 21 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| Christopher Graja | Argus Research Company |
| Lauren Lieberman | Barclays |
| Lauren Lieberman | Barclays |